Sudarshan Pharma Industries

Sector: Healthcare

Followers

6
6
3
3
.
4
4
2
2
-0.64 (-2.56%)

As on 11 Dec, 2025 | 16:01

Open Trading A/c
Day Range
24.30
25.24
LH
52 Week Range
22.33
53.50
LH
Volume
* i
Bid / Ask
20,000.00
0.00 / 0.00

Sudarshan Pharma Industries Announcements

Please find enclosed the Notice of Postal Ballot together with explanatory statement sent to the members of the Company.

11 Dec, 2025 | 11:13am • Source: BSE

Please find attached copy of certificates received from Kfin Technologies Limited, Registrar & Share Transfer Agent under Regulation 74(5) of SEBI (Depository & Participants) Regulations,...

20 Oct, 2025 | 12:32pm • Source: BSE

Please find enclosed the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-September-2025 published in Mumbai...

20 Oct, 2025 | 12:25pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we inform you that w.e.f. 18-October-2025, Dr. Umesh Luthra has resigned as...

19 Oct, 2025 | 08:47am • Source: BSE

Pursuant to Regulation 33 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find attached the Unaudited Financial Results for the quarter and half...

18 Oct, 2025 | 09:16pm • Source: BSE

Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2025 ,inter alia, to consider...

15 Oct, 2025 | 06:56pm • Source: BSE

The Trading Window of the Company shall remain closed with effect from October 1, 2025 until the expiry of 48 hours after the declaration of...

30 Sep, 2025 | 02:46pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, the Company would like to intimate an update in respect of the...

08 Sep, 2025 | 05:28pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of our earlier intimation dated August 14, 2025, please...

08 Sep, 2025 | 04:29pm • Source: BSE

This is in reply to the query received from BSE dated 18th August 2025 pertaining to resignation of Mr. Manoj Lodha as Chief Financial Officer...

18 Aug, 2025 | 03:46pm • Source: BSE

Please find enclosed herewith the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2025, published in Financial...

18 Aug, 2025 | 11:34am • Source: BSE

Please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through...

12 Aug, 2025 | 05:10pm • Source: BSE

Please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through...

12 Aug, 2025 | 05:05pm • Source: BSE

Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider...

11 Aug, 2025 | 04:17pm • Source: BSE

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations And Disclosure REquirements) Regulations, 2015, we enclose herewith the summary of...

11 Aug, 2025 | 02:52pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Manoj Lodha has resigned as...

05 Aug, 2025 | 07:02pm • Source: BSE

In continuation of the Company''s disclosure dated 16/Jan/2025 regarding approval of the Board to acquire 300 shares of AED 1000/- each of M/s. Cibachem General...

05 Aug, 2025 | 06:59pm • Source: BSE

Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find attached the Scrutinizer''s Report on the business transacted at the...

25 Jul, 2025 | 08:08pm • Source: BSE

Pursuant to Regulation 44(3) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find attached the voting results on the business transacted at the...

25 Jul, 2025 | 07:57pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Proceedings of the 17th Annual General Meeting of...

25 Jul, 2025 | 05:08pm • Source: BSE